Find the latest oncology news for your sub-specialty area
Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8…
Anthracyclines are among the most widely used chemotherapy drugs and have been a mainstay of…
Clinical trials are essential to improving outcomes for children and adolescents with cancer, but access…
In a recent Viewpoint in JAMA Oncology, a group of oncology ethicists and clinicians examine…
A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by…
Ipsen Australia welcomes the Pharmaceutical Benefits Scheme (PBS) listing of Cabometyx® (cabozantinib) for the treatment…
The National Comprehensive Cancer Network (NCCN) has updated its Breast Cancer Guidelines to acknowledge the…
A new study in the British Journal of Cancer has used nearly seven decades of…
Australian researchers have discovered that the TAK1 gene helps cancer cells survive immune system attacks,…
University of Navarra (Spain) researchers have developed RNACOREX, a new open-source software capable of identifying…